We developed a telomerase-positive, infinite life span human fibroblast cell strain (MSU-1.0) by transfection of a v-MYC oncogene and spontaneous over-expression of transcription factors SP1/SP3. Loss of expression of p14 ALT and enhanced expression of SPRY2 gave rise to the MSU-1.1 cell strain. Unlike MSU-1.0 cells, the MSU-1.1 cells can be malignantly transformed by expression of N-RAS LYS61 or H-Ras v12 oncoproteins (driven by their original promoters) and expression of a SRC-family protein, v-FES. MSU-1.1 cells can also be malignantly transformed by high expression of these RAS oncogenes or the v-K-RAS oncogene. PDGF-B transformed MSU-1.1 cells give rise to benign tumors (fibromas) in athymic mice. A second route to malignant transformation of the MSU-1.1 cells involves loss of functional TP53 protein by carcinogen treatment and loss of expression of wild type p16 INK. These studies indicate 6-8 "hits" are required to activate the oncogenes and inactivate the suppressor genes we identified. © 2011 Springer Science+Business Media, LLC.
CITATION STYLE
McCormick, J. J., & Maher, V. M. (2011). Malignant transformation of human skin fibroblasts by two alternative pathways. In Advances in Experimental Medicine and Biology (Vol. 720, pp. 191–207). https://doi.org/10.1007/978-1-4614-0254-1_16
Mendeley helps you to discover research relevant for your work.